| Sources | Names Used |
|---|---|
| CTRPv2 | ML334 diastereomer |
| PharmacoGx | ML334 diastereomer |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WBP2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | OR7C1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | ANO10 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | NR2E3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | TACC3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | ZNF695 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | HECTD2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | HLF | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | RB1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | PUS10 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
